Reanalysis of the TCGA-PAAD cohort (n = 176) showed moderate positive correlation between FGFR1 and PARP1 mRNA expression (Spearman’s R: 0.4; Pearson’s R: 0.1) (Figure 3B). The gene discussed is FGFR1; the disease is pancreatic adenocarcinoma.